Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary Ataxias in Argentina. | Cerebellum | 2025 | 40198507 | PubTator, text mining | PubMed |
| DRFormer: A Benchmark Model for RNA Sequence Downstream Tasks. | Genes (Basel) | 2025 | 40149436 | PubTator, text mining | PubMed |
| Epidemiology of Autosomal Dominant Spinocerebellar Ataxias in Latin America: A Systematic Review and Meta-Analysis. | Cerebellum | 2025 | 40138010 | PubTator, text mining | PubMed |
| Explainable machine learning models enhance prediction of PFAS bioactivity using quantitative molecular surface analysis-derived representation. | Water Res | 2025 | 40107212 | PubTator, text mining | PubMed |
| Polyglutamine Ataxias in Denmark: Incidence and Relative Frequencies of SCA1, 2, 3, 6, 7, 17 and DRPLA in a Nationwide Cohort. | Cerebellum | 2025 | 40085370 | PubTator, text mining | PubMed |
| The LSmAD Domain of Ataxin-2 Modulates the Structure and RNA Binding of Its Preceding LSm Domain. | Cells | 2025 | 40072111 | PubTator, text mining | PubMed |
| Analysis of Short Tandem Repeat Expansions in a Cohort of 12,496 Exomes from Patients with Neurological Diseases Reveals Variable Genotyping Rate Dependent on Exome Capture Kits. | Genes (Basel) | 2025 | 40004498 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases. | Genes (Basel) | 2025 | 40004464 | PubTator, text mining | PubMed |
| Three Cases of Spinocerebellar Ataxia Type 2 (SCA2) and Pediatric Literature Review: Do Not Forget Trinucleotide Repeat Disorders in Childhood-Onset Progressive Ataxia. | Brain Sci | 2025 | 40002489 | PubTator, text mining | PubMed |
| TDP-43 Aggregate Seeding Impairs Autoregulation and Causes TDP-43 Dysfunction. | bioRxiv | 2025 | 39990366 | PubTator, text mining | PubMed |
| HTT, ATXN1 and ATXN2 CAG triplet repeat sizes: exploring their role in the disease risk and cancer comorbidity in Parkinson's disease. | Brain Commun | 2025 | 39974178 | PubTator, text mining | PubMed |
| An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2. | Eur J Hum Genet | 2025 | 39956874 | PubTator, text mining | PubMed |
| Localization of Potential Energy in Hydrogen Bonds of the ATXN2 Gene. | Int J Mol Sci | 2025 | 39940702 | PubTator, text mining | PubMed |
| Molecular determinants of condensate composition. | Mol Cell | 2025 | 39824169 | PubTator, text mining | PubMed |
| ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. | Cerebellum | 2025 | 39820777 | PubTator, text mining | PubMed |
| The Rickettsia actin-based motility effectors RickA and Sca2 contribute differently to cell-to-cell spread and pathogenicity. | mBio | 2025 | 39819005 | PubTator, text mining | PubMed |
| ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS). | Neurogenetics | 2025 | 39804470 | PubTator, text mining | PubMed |
| The interaction of Serratia bacteria and harmonine in harlequin ladybird confers an interspecies competitive edge. | Proc Natl Acad Sci U S A | 2025 | 39793111 | PubTator, text mining | PubMed |
| Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin-sensitive imaging. | Eur J Neurol | 2025 | 39757380 | PubTator, text mining | PubMed |
| Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases. | J Transl Autoimmun | 2025 | 39741931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=7